Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

The impact of the SARS-CoV-2 pandemic and COVID-19 on lung transplantation in the UK: Lessons learned from the first wave

Lookup NU author(s): Gillian Hardman, Stephen Clark, Karen Booth, Professor John Dark, Professor Andrew FisherORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND).


Abstract

© 2021 The Authors. Clinical Transplantation published by John Wiley & Sons Ltd.Background: Lung transplantation is particularly susceptible to the impact of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic, and evaluation of changes to practice is required to inform future decision-making. Methods: A retrospective review of the UK Transplant Registry (UKTR) and national survey of UK lung transplant centers has been performed. Results: There was geographic variation in the prevalence of COVID-19 infection across the UK. The number of donors fell by 48% during the early pandemic period. Lung utilization fell to 10% (compared with 24% for the same period of 2019). The number of lung transplants performed fell by 77% from 53, March to May 2019, to 12. Seven (58%) of these were performed in a single-center, designated “COVID-light.” The number of patients who died on the lung transplant waiting list increased, compared to the same period of 2019 (p =.0118). Twenty-six lung transplant recipients with confirmed COVID-19 infection were reported during the study period. Conclusion: As the pandemic continues, reviewing practice and implementing the lessons learned during this period, including the use of robust donor testing strategies and the provision of “COVID-light” hospitals, are vital in ensuring the safe continuation of our lung transplant program.


Publication metadata

Author(s): Hardman G, Sutcliffe R, Hogg R, Mumford L, Grocott L, Mead-Regan S-J, Nuttall J, Dunn S, Seeley P, Clark S, Quigley R, Al-Attar N, Booth K, Dark JH, Fisher AJ

Publication type: Article

Publication status: Published

Journal: Clinical Transplantation

Year: 2021

Volume: 35

Issue: 3

Print publication date: 01/03/2021

Online publication date: 25/12/2020

Acceptance date: 21/12/2020

Date deposited: 19/03/2021

ISSN (print): 0902-0063

ISSN (electronic): 1399-0012

Publisher: Blackwell Publishing Ltd

URL: https://doi.org/10.1111/ctr.14210

DOI: 10.1111/ctr.14210

PubMed id: 33368697


Altmetrics

Altmetrics provided by Altmetric


Share